L-778,123
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for L-778,123, covering 2013-06-21 to 2013-06-25. Get the full timeline:
Most recent: Clinical Trial Update: L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors [Phase 1]